Cor Vasa 2010, 52(1-2):30-35 | DOI: 10.33678/cor.2010.006
Primary prevention of sudden cardiac death - ICDs for every patient with ventricular dysfunction?
- Interní kardiologická klinika, Fakultní nemocnice Brno, Česká republika
Despite advances in the diagnosis and treatment of cardiac diseases, sudden cardiac death remains a most topical problem. Implantable cardioverter-defibrillators (ICDs) have been used in sudden cardiac death prevention for almost three decades. A major breakthrough has occurred over the last ten years. The number of secondary prevention ICD implantations has remained nearly stable whereas that of primary prevention ICD recipients has increased. As the number of ICD-indicated patients increases, ICD efficacy declines and costs rise dramatically. The objective of this paper is to put the guidelines for primary prevention ICD implantation into context of results of large multicenter studies. The article tries to define the profile of patients who fail to benefit from ICD implantation even though meeting the primary prevention criteria.
Keywords: Implantable cardioverter-defibrillator; Sudden cardiac death; Primary prevention
Published: January 1, 2010 Show citation
References
- Passman R, Kadish A. Sudden death prevention with implantable devices. Circulation 2007;116:561-571.
Go to original source...
Go to PubMed...
- Zimerman LI. Cardioverter-defibrillator in the primary prevention of sudden death for all or for a few? Arq Bras Cardiol 2008;1:63-64.
- Dorian P, Talajic M, Tang A. Implantable cardioverter defibrillators for the prevention of sudden death. Can J Cardiol 2005;21:31A-36A.
- Moss AJ, Hall WJ, Cannom DS, et al. Improved survival with an implanted defibrillator in patients with coronary disease at high risk for ventricular arrhythmia. Multicenter Automatic Defibrillator Implantation Trial Investigators. N Engl J Med 1996;335:1933-1940.
Go to original source...
Go to PubMed...
- Moss AJ, Zareba W, Hall WJ, et al. Multicenter Automatic Defibrillator Implantation Trial II Investigators. Prophylactic implantation of a defibrillator in patients with myocardial infarction and reduced ejection fraction. N Engl J Med 2002;346:877-883.
Go to original source...
Go to PubMed...
- Bardy GH, Lee KL, Mark DB, et al. Sudden Cardiac Death in Heart Failure Trial (SCD-HeFT) Investigators. Amiodarone or an implantable cardioverter-defibrillator for congestive heart failure. N Engl J Med 2005;352:225-237.
Go to original source...
Go to PubMed...
- Banch D, Antz M, Boczor S, et al. Primary prevention of sudden cardiac death in idiopathic dilated cardiomyopathy. The Cardiomyopathy Trial (CAT). Circulation 2002;105:1453-1458.
Go to original source...
Go to PubMed...
- Wijetunga M, Strickberger SA. Amiodarone Versus Implantable Defibrillator Randomized Trial (AMIOVIRT): Background, rationale, design, methods, results and implications. Card Electrophysiol Rev 2003;7:452-456.
Go to original source...
Go to PubMed...
- Bigger JT jr. Prophylactic use of implanted cardiac defibrillators in patients at high risk for ventricular arrhythmias after coronary-artery bypass graft surgery. Coronary Artery Bypass Graft (CABG) Patch Trial Investigators. N Engl J Med 1997;337:1569-1575.
Go to original source...
Go to PubMed...
- Connolly SJ, Dorian P, DINAMIT Investigators. Randomized trial of ICD after recent acute myocardial infarction: DINAMIT. Can J Cardiol 2004;20 (Suppl D):146D.
- Anderson R., Salomon SD. Sudden death in patients with myocardial infarction. http://www.cardiologyreviewonline.com/issues/articles/2006-04_05.asp.
- Táborský M. za pracovní skupinu Arytmie a trvalá kardiostimulace. Zásady pro implantace kardiostimulátorů, implantabilních kardioverterů-defibrilátorů a systémů pro srdeční resynchronizační léčbu 2009. Cor Vasa 2009;51(9):602-614.
Go to original source...
- Carrim ZI, Khan AA, Aslam S. Primary prevention of fatal ventricular arrhythmias with implantable cardioverter defibrillator therapy - an analysis of implications based on MADIT II criteria. Mcgill J Med 2006;9:14-18.
Go to original source...
- Henyan NN, White CM, Gillespie EL, et al. The impact of gender on survival amongst patients with implantable cardioverter defibrillators for primary prevention against sudden cardiac death. J Intern Med 2006;260: 467-473.
Go to original source...
Go to PubMed...
- Russo AM, Poole JE, Mark DB, et al. Primary prevention with defibrillator therapy in women: Results from the Sudden Cardiac Death in Heart Failure Trial. J Cardiovasc Electrophysiol 2008;19:720-724.
Go to original source...
Go to PubMed...
- Sweeney MO, Hellkamp AS, Ellenbogen KA, et al. Reduced ejection fraction, sudden cardiac death, and heart failure death in the Mode Selection Trial (MOST): Impliciations for device selection in elderly patients with sinus node disease. J Cardiovasc. Electrophysiol 2008;19:1160-1166.
Go to original source...
Go to PubMed...
- Setoguchi S, Nohria A, Rassen JA, et al. Maximum potential benefit of implantable defirbillators in preventing sudden death after hospital admission because of heart failure. CMAJ 2009;180:611-616.
Go to original source...
Go to PubMed...
- Boriani G. Cardioverter defibrillators in primary prevention of sudden cardiac death: a cost or an investment? Value Health 2007;10:1-2.
Go to original source...
Go to PubMed...
- Huang DT, Sesselberg HW, McNitt S, et.al. Improved survival associated with prophylactic implantable defibrillators in eldery patients with prior myocardial infarction and depressed ventricular function. J Cardiovasc Electrophysiol 2007;18:833-838.
Go to original source...
Go to PubMed...
- Goldenberg I, Vyas AK, Hall WJ, et al. Risk stratification for primary implantation of a cardioverter defibrillator in patients with ischemic left ventricular dysfunction. J Am Coll Cardiol 2008;51:288-296.
Go to original source...
Go to PubMed...
- Tung R, Swerdlow CD. Refining patient selection for primary prevention implantable cardioverter defibrillator therapy: Reeling in a net cast too widely. Circulation 2009;120:825-827.
Go to original source...
Go to PubMed...
- Barthel P, Bauer A, Schneider R, et al. Prolonged QRS duration is an independent risk predictor after acute myocardial infarction. PACE 2003;26(4) II:943.
Go to PubMed...
- Kalahasti V, Nambi V, Martin DO, et al. QRS duration and prediction of mortality in patients undergoing risk stratification for ventricular arrhythmias. Am J Cardiol 2003;92:798-803.
Go to original source...
Go to PubMed...
- Zipes PD, Camm AJ, Borggrefe M, et al. ACC/AHA/ESC 2006 Guidelines for management of patients with ventricular arrhythmias and the prevention of sudden cardiac death. J Am Coll Cardiol 2006;48:1064-1108.
Go to original source...
- Bloomfield DM, Bigger JT, Steinman R, et al. Microvolt T-wave alternans and the risk of death or sustained ventricular arrhythmias in patients with left ventricular dysfunction. J Am Coll Cardiol 2006;47:456-463.
Go to original source...
Go to PubMed...
- Chan PS, Stein K, Chow T, et al. Cost-effectiveness of a microvolt T-wave alternans screening strategy for implantable cardioverter-defibrillator placement in the MADIT-II-eligible population. J Am Coll Cardiol 2006;48: 112-121.
Go to original source...
Go to PubMed...
- Moss AJ. Implantable cardioverter defibrillator therapy. The sickest patients benefit the most. Circulation 2000;101:1638-1640.
Go to original source...
Go to PubMed...
- Jolly S, Dorian P, Alter DA. The impact of implantable cardiac defibrillators for primary prophylaxis in the community: baseline risk and clinically meaningful benefits. Journal of evaluation in clinical practice 2005;12: 190-195.
Go to original source...
Go to PubMed...
- Gehi A, Haas D, Fuster V. Primary prophylaxis with the implantable cardioverter defibrillator. The need for improved risk stratification. JAMA 2005;8: 958-960.
Go to original source...
Go to PubMed...
- Dorian P. Effective and efficient use of implantable defibrillators: sometimes it's over when it's over. CMAJ 2009;180(6):599-600.
Go to original source...
Go to PubMed...
- Struthers A, Lang C. The potential to improve primary prevention in the future by using BNP/N-BNP as an indicator of silent pancardiac target organ damage. Eur Heart J 2007;28:1678-1682.
Go to original source...
Go to PubMed...
- Bundkirchen A, Schwinger RH. Epidemiology and economic burden of chronic heart failure. Eur Heart J 2004;6:D57-D60.
Go to original source...